UK advances major veterinary reforms tied to pet care costs

The UK is moving ahead with sweeping veterinary-sector reforms after years of mounting concern over rising pet care costs, opaque pricing, and the rapid corporatization of practice ownership. On January 27, 2026, the Department for Environment, Food & Rural Affairs opened an eight-week consultation on reforming the Veterinary Surgeons Act 1966, framing it as the first major overhaul of the sector in six decades. The consultation arrived after the Competition and Markets Authority said problems in the veterinary market could cost households up to £1 billion over five years and that veterinary fees had risen at nearly twice the rate of inflation. (gov.uk)

The background here matters. The CMA began reviewing the UK veterinary market in September 2023, escalated to a formal market investigation in May 2024, and later extended the statutory deadline in June 2025 because of the scale and complexity of the inquiry. The regulator said it received about 56,000 responses during its early evidence-gathering, including roughly 11,000 from people working in the veterinary sector. That inquiry increasingly focused on weak price transparency, concerns about medicine costs, limited consumer understanding of corporate ownership, and the fact that the legal framework was built around regulating individual veterinary surgeons, not modern veterinary businesses. (gov.uk)

Defra’s reform package is designed to modernize that framework. According to the government, the proposals include a new licensing system for veterinary businesses, enforcement powers that could include loss of license, and a more modern disciplinary process with a wider range of sanctions. Defra said 60% of veterinary practices are owned by non-vets, underscoring why business-level oversight has become a policy priority. In parallel, the CMA’s final remedies package requires clearer pricing and disclosure measures, including written estimates in advance for treatment expected to cost £500 or more, plus itemized bills, as part of a broader push to help pet parents compare options and avoid unexpected charges. (gov.uk)

The corporate context has been building for years. CMA materials identify six large veterinary groups, CVS, IVC, Linnaeus, Medivet, Pets at Home, and VetPartners, as central players in the market. Earlier CMA reporting also found that treatment prices rose 60% between 2015 and 2023, compared with 35% inflation in general services, while independent practices’ share of the market fell sharply over the last decade. That doesn’t mean the investigation was framed as an indictment of frontline clinicians. In fact, both the CMA and RCVS have emphasized that most pet parents remain satisfied with the professional care delivered by individual vets and veterinary nurses, even as concerns persist around the commercial relationship and consumer experience. (gov.uk)

Sector reaction has been broadly supportive of modernization, with caveats. The RCVS said it welcomed the CMA’s focus on transparency, pricing, legislative reform, greater use of veterinary nurses, and regulation of practices, and later said it broadly welcomed the CMA’s proposals while raising governance concerns. The British Veterinary Association also welcomed the government’s January 2026 consultation, saying it reflected years of campaigning to update the outdated 1966 law. Consumer group Which? backed the changes as well, while pressing for strong sanctions and a mandatory ombudsman scheme. That mix of support and caution suggests the debate has shifted from whether reform is needed to how far it should go, and how implementation can avoid unintended burdens. (rcvs.org.uk)

Why it matters: For veterinary professionals, the significance is twofold. First, the UK is testing a more explicit model of business regulation in companion animal practice, one that could reshape accountability for pricing, disclosures, complaints handling, and ownership transparency. Second, it reflects a broader policy argument that animal welfare, consumer trust, and commercial oversight can’t be separated in a modern, consolidated veterinary market. For practice leaders, this may mean new systems for estimates, billing, website disclosures, and governance. For clinicians, it could also change how commercial policies are scrutinized when they intersect with prescribing, referrals, or client decision-making. For US readers, the story is worth watching because it shows how competition regulators may respond when consolidation and affordability concerns move from professional debate into mainstream politics. (gov.uk)

What to watch: The immediate next step is Defra’s review of consultation responses after the eight-week window that opened in late January 2026, alongside implementation planning for the CMA’s remedies and any eventual legislation to replace or substantially revise the Veterinary Surgeons Act 1966. The key question is no longer whether the UK wants more oversight of veterinary businesses, but how quickly those rules arrive, how they’re enforced, and whether they reduce costs for pet parents without adding unsustainable pressure on practices and teams. (gov.uk)